Recent advances in the treatment of epilepsy

Archives of Neurology

Volumn 60, Issue 7, 2003, Pages 929-935

  Nguyen, Dang K ^b   Spencer, Susan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CORTICOTROPIN; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; REMACEMIDE; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; APLASTIC ANEMIA; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; DISEASE EXACERBATION; DRUG APPROVAL; DRUG EFFICACY; EPILEPSY; EPILEPTIC STATE; FOCAL EPILEPSY; GAMMA KNIFE RADIOSURGERY; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; LIVER FAILURE; MEDICAL DECISION MAKING; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; WEST SYNDROME;

ANTICONVULSANTS; BRAIN; CLINICAL TRIALS; EPILEPSY; HUMANS; RADIOSURGERY; VAGUS NERVE;

EID: 0038375849     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.7.929     Document Type: Review

References (95)

1. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia. 2001;42:1255-1260.
2. Chadwick D. Monotherapy comparative trials: equivalence and differences in clinical trials. Epilepsy Res. 2001;45:101-103.
3. Beydoun A, Milling CJ. Active-control comparative equivalency monotherapy trials in epilepsy: are they scientifically valid? Epilepsy Behav. 2001;2:187-192.
4. Schwabe SK. Challenges in the clinical development of new antiepileptic drugs. Ther Drug Monit. 2002;24:81-84.
5. Wiebe S. An evidence based approach to the first unprovoked seizure. Can J Neurol Sci. 2002;29:120-124.
6. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41:965-972.
7. First Seizure Trial Group (FIR.S.T. Group). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology. 1993;43(3, pt 1):478-483.
8. Gilad R, Lampl Y, Gabbay U, Eshel Y, Sarova-Pinhas I. Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol. 1996;53:1149-1152.
9. Hauser WA, Anderson VE, Loewenson RB, McRoberts SM. Seizure recurrence after a first unprovoked seizure. N Engl J Med. 1982;307:522-528.
10. Deckers CLP, Hekster YA, Keyser A, et al. Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia. 2001;42:1387-1394.
11. Stefan H, Halasz, P, Gil-Nagel A, et al. Recent advances in the diagnosis and treatment of epilepsy. Eur J Neurol. 2001;8:519-539.
12. Chadwick D, Leiderman DB, Sauermann W, Alexander J, Garofalo E. Gabapentin in generalized seizures. Epilepsy Res. 1996;25:191-197.
13. Biton V, Montouris GD, Ritter F, et al, for the Topiramate YTC Study Group. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology. 1999;52:1330-1337.
14. Mikati MA, Holmes GL. Lamotrigine in absence and primary generalized epilepsies. J Child Neurol. 1997;12(suppl 1):S29-S37.
15. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40:973-979.
16. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol. 1989;27(suppl 1):101S-107S.
17. Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 1989;3:70-76.
18. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27:205-213.
19. Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 1997;27:195-204.
20. Christe W, Kramer G, Vigonius U, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 1997;26:451-460.
21. Brodie MJ, Richens A, Yuen AW, for the UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet. 1995;345:476-479.
22. Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res. 1996;23:149-155.
23. Nieto-Barrera M, Brozmanova M, Capovilla G, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46:145-155.
24. Brodie MJ, Overstall PW, Giorgi L, for the UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999;37:81-87.
25. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 1999;40:601-607.
26. Chadwick DW, Anhut H, Greiner MJ, et al, for the International Gabapentin Monotherapy Study Group. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology. 1998;51:1282-1288.
27. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia. 2002;43:993-1000.
28. Chadwick D, for the Vigabatrin European Monotherapy Study Group. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicenter randomized double-blind study. Lancet 1999;354:13-19.
29. Brodie MJ. Monotherapy trials: prerequisite data. Epilepsy Res. 2001;45:61-64.
30. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med. 1993;328:29-33.
31. Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, cross-over study. Epilepsia. 1998;39:495-501.
32. Beran RG, Berkovic SF, Dunagan FM, et al. Double-blind, placebo-controlled, cross-over study of lamotrigine in treatment-resistant generalized epilepsy. Epilepsia. 1998;39:1329-1333.
33. Biton V, Montouris GD, Ritter F, et al, for the Topiramate YTC Study Group. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology. 1999;52:1330-1337.
34. Sachdeo RC, Glauser TA, Ritter F, et al, for the Topiramate YL Study Group. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology. 1999;52:1882-1887.
35. Hrachovy RA, Frost JD Jr, Kellaway P, Zion TE. Double-blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr. 1983;103:641-645.
36. Appleton RE, Peters AC, Mumford JP, Shaw DE. Randomized, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40:1627-1633.
37. Elterman RD, Shields WD, Mansfield KA, Nakagawa J, for the US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology. 2001;57:1416-1421.
38. Suzuki Y, Nagai T, Ono J, et al. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia. 1997;38:1035-1038.
39. Traverse LD. Successful zonisamide treatment for infants with hypsarrythmia [letter]. Pediatr Neurol. 2001;25:422.
40. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 1996;313:1169-1174.
41. Marson AG, Hutton JL, Leach JP, et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res. 2001;46:259-270.
42. Cramer JA, Ben Menachem E, French J. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res. 2001;47:17-25.
43. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). Epilepsy Res. 2001;43:11-58.
44. Arroyo S, de la Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res. 2001;47:155-174.
45. Anhut H, Ashman P, Feuerstein TJ, et al. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia. 1994;35:795-801.
46. Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia. 1991;32:539-542.
47. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet. 1990;335:1114-1117.
48. UK Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology. 1993;43:2292-2298.
49. Appleton R, Fichtner K, LaMoreaux L, et al, for the Gabapentin Pediatric Study Group. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicenter, double-blind, placebo-controlled study. Epilepsia. 1999;40:1147-1154.
50. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy [Cochrane Review on CD-ROM]. Oxford, England: Update Sottware; 2002;issue 2.
51. Frank LM, Enow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40:973-979.
52. Gilliam F, Vazquez B, Sackellares JC, et al. An active control trial of lamotrigine monotherapy for partial seizures. Neurology. 1998;51:1018-1025.
53. Crawford P, Richens A, Mawer G, Cooper P, Hutchison JB. A double-blind placebo controlled cross-over study of remacemide hydrochloride as adjunctive therapy in patients with refractory epilepsy. Epilepsy Res. 1992;1 (suppl):S7-S13.
54. Sharief M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 1996;25:217-224.
55. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia. 1996;37:763-768.
56. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia. 1996;37:539-543.
57. Glauser TA, Clark PO, McGee K, for the YL Study Group. Long-term response to topiramate in patients with West's syndrome: open-label treatment of patients completing a randomized trial. Epilepsia. 2000;41:91-94.
58. Glauser TA, Sachdeo RC, Ritter F, Sachdeo RC, for the Topiramate YL Study Group. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized trial. Epilepsia. 2000;41:86-90.
59. Gilliam FG, Reife RA, Wu SC. Topiramate monotherapy: randomized controlled trial in patients with recently diagnosed localization-related epilepsy [abstract]. Neurology. 1999;52(suppl 2):A248.
60. Lassen LC, Sommerville K, Mengel HB, et al. Summary of five controlled trials with tiagabine as adjunctive treatment of patients with partial seizures [abstract]. Epilepsia. 1995;36(suppl 3):S148.
61. Pellock JM. Tiagabine (Gabitril) experience in children. Epilepsia. 2001;42 suppl 3):49-51.
62. Rimmer EM, Richens A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet. 1984;1:189-190.
63. Gram L, Klosterskov P, Dam M. Gamma-vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol. 1985;17:262-266.
64. Tartara A, Manni R, Galimberti CA, et al. Vigabatrin in the treatment of epilepsy: a double-blind placebo-controlled study. Epilepsia. 1986;27:717-723.
65. Loiseau P, Hardenberg JP, Pestre M, et al. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug resistant epilepsy: a double-blind, placebo controlled study. Epilepsia. 1986;27:717-723.
66. Tassinari CA, Michelucci R, Ambroseto G, Salvi F. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol. 1987;44:907-910.
67. Bruni J, Guberman A, Vachon L, et al, for the Canadian Vigabatrin Study Group. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicenter study. Seizure. 2000;9:224-232.
68. Malmgren K, Ben-Menachem E, Frisen L. Vigabatrin visual toxicity: evolution and dose dependence. Epilepsia. 2001;42:609-615.
69. Appleton RE, Peters ACB, Mumford JP, Shaw DE. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40:1627-1633.
70. Lortie A, Chiron C, Mumford J, Duloc O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology. 1993;43(suppl 5):S24-S27.
71. Bares G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled dose-ranging trial in refractory partial epilepsy. Epilepsia. 2000;41:1597-1607.
72. Glauser TA, Nigro M, Sachdea R, et al, for the Oxcarbazepine Pediatric Study Group. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology. 2000;54:2237-2242.
73. Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 1999;52:732-737.
74. Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology. 2000;54:2245-2251.
75. Cereghino JJ, Biton V, Abou-Khalil B, et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology. 2000;55:236-242.
76. Shorwon SD, Lowenthal A, Janz D, et al. Multcenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia. 2000;41:1179-1186.
77. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia. 2000;41:1276-1283.
78. Leppik IE, Willmore LJ, Homan RW, et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res. 1993;14:165-173.
79. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res. 1993;15:67-73.
80. Faught E, Ayala R, Montouris GG, et al. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology. 2001;57:1774-1779.
81. Spencer SS, Sperling MR, Shewmon DA. Intracranial electrodes. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, Pa: Lippincott-Raven Publishers; 1998:1719-1748.
82. Wiebe S, Blume WT, Girvin JP, et al, for the Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-318.
83. Morrell F, Whisler WW, Bleck T. Multiple subpial transection: a new approach to the surgical treatment of focal epilepsy. J Neurosurg. 1989;70:231-239.
84. Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome: treatment with subpial intracortical transection. Brain. 1995;118:1529-1546.
85. Spencer SS, Schramm J, Wyler A, et al. Multiple subpial transection for intractable partial epilepsy: an international meta-analysis. Epilepsia. 2002;43:141-145.
86. Regis J, Bartolomei F, Kida Y, et al. Radiosurgery for epilepsy associated with cavernous malformations: a retrospective study in 49 patients. Neurosurgery. 2000;47:1091-1097.
87. Regis J, Bartolomei F, de Toffol B, et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Neurosurgery. 2000;47:1343-1351.
88. Regis J, Bartolomei R, Rey M, Hayashi M, Chauvel P, Peragut JC. Gamma knife surgery for mesial temporal lobe epilepsy. J Neurosurg. 2000;93(suppl 3):141-146.
89. Binnie CD. Vagus nerve stimulation for epilepsy: a review. Seizure. 2000;9:161-169.
90. Vagus Nerve Stimulation Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology. 1995;45:224-230.
91. Handforth A, DeGiorgio CM, Schlachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51:48-55.
92. Patwardhan RV, Stong B, Bebin M, Mathisen J, Grabb PA. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery. 2000;47:1353-1358.
93. Lundgren J, Amark P, Blennow G, Stromblad LG, Wallsted L. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia. 1998;39:809-813.
94. Loddenkemper T, Pan A, Neme S, et al. Deep brain stimulation in epilepsy. J Clin Neurophysiol. 2001;18:514-532.
95. Fisher RS, Uematsu S, Krauss GL, et al. Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia. 1992;33:841-851.